Miniaturisation is the core theme of our research aiming to address some of the world’s most pressing health technology problems.
The Centre solves technical problems associated with the availability, accessibility and affordability of point-of-care diagnostics, drug delivery and advanced medical equipment.
Spiralling costs compounded by chronic underfunding and ageing populations have placed significant burdens on global healthcare, therefore requiring radical solutions, such as personalised medicine and advanced medical technology at lower costs and greater sophistication.
Integral to this framework is the Centre’s aim to improve the availability, accessibility, and affordability of point-of-care diagnostics, drug delivery platforms and biosensors, which could revolutionise public health by equipping medical practitioners, healthcare providers and aid workers with advanced tools for the diagnosis, prognosis and treatment of preventable diseases.
With our team of around 35 postgraduate students and post-doctoral staff, we are directing and resources and abilities to Australia’s most pressing problems, including development of portable handheld aerosol drug delivery devices for pulmonary gene delivery and vaccination.
Groundbreaking fundamental and applied research in the Centre has led to the development of completely integrated low-cost portable devices for drug delivery and ultrasensitive chemical detection which are amongst the smallest compared to that available in the market. The Centre’s work is, for example, opening up new avenues for roadside testing of illicit drugs.
Current trials are also underway to demonstrate effective inhaled delivery of next generation therapeutics such as peptides, monoclonal antibodies and siRNA for a wide range of pulmonary diseases.
The core theme that weaves together the Centre’s activities is miniaturisation—using novel physics and engineering, our interdisciplinary team of researchers aim to miniaturise laboratory-scale processes and conventional medical procedures and protocols onto chip-scale devices which can be integrated to form the state-of-the-art in medical technology.
The Centre is home to a wealth of world-leading interdisciplinary expertise in fluid physics, colloid and interface science, photonics, acoustics, optics, nanofabrication, nanomaterials, polymer chemistry and applied mathematics.
In 2014, RMIT University opened the $30 million state-of-the-art MicroNano Research Facility to support high quality micro and nano research and foster collaboration between researchers, institutions and industry.
The facility includes a huge cleanroom and cell laboratory and nanofabrication and characterisation equipment. This includes third laser nanolithography, chemical vapor deposition, thin film deposition, deep reactive ion etching, focused ion beam milling, biological atomic force microscopy, scanning electron microscopy, confocal microscopy, flow cytometry and state-of-the-art UV equipment.